No benefit of chlamydia screening in primary care?

Lancet. 2018 Oct 20;392(10156):1381-1383. doi: 10.1016/S0140-6736(18)32465-6.

Authors

Paul C Adamson¹, Jeffrey D Klausner²

Affiliations

¹ Division of Infectious Diseases, David Geffen School of Medicine at University of California, Los Angeles, CA 90025, USA.
² Division of Infectious Diseases, David Geffen School of Medicine at University of California, Los Angeles, CA 90025, USA. Electronic address: jdklausner@mednet.ucla.edu.

PMID: 30343849
DOI: 10.1016/S0140-6736(18)32465-6

No abstract available

Publication types

Comment

MeSH terms

Chlamydia Infections*
Chlamydia trachomatis
Chlamydia*
Humans
Mass Screening
Primary Health Care